RGLS

Regulus Therapeutics
RGLS

Overview Fund Activity
Delisted

RGLS was delisted on the 24th of June, 2025.

Back to rankings

48 hedge funds and large institutions have $77.2M invested in Regulus Therapeutics in 2017 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 18 increasing their positions, 13 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
48
Holders Change
+2
Holders Change %
+4.35%
% of All Funds
1.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
18
Reduced
13
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
NMC
1
NEA Management Company
Maryland
$13.7M
2
BI
2
BVF Inc
California
$16.2M
3
Fidelity Investments
3
Fidelity Investments
Massachusetts
$19.5M
4
BC
4
Broadfin Capital
New York
$5.37M
5
BC
5
Boxer Capital
California
$2.75M

Top Sellers

1
Goldman Sachs
1
Goldman Sachs
New York
$0
2
ARTA
2
A.R.T. Advisors
New York
$31K
3
Wells Fargo
3
Wells Fargo
California
$615K
4
LP
4
LMR Partners
United Kingdom
$0
5
PP
5
Paloma Partners
Connecticut
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Susquehanna International Group
51
Susquehanna International Group
Pennsylvania
– -$63K -529 Closed
Citadel Advisors
52
Citadel Advisors
Florida
– -$11K -94 Closed
Group One Trading
53
Group One Trading
Illinois
– -$9K -78 Closed
PAM
54
Panagora Asset Management
Massachusetts
– -$2K -16 Closed
Manulife (Manufacturers Life Insurance)
55
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$1K -12 Closed
1 2
3